FCN2 and Hepatic fibrosis: Our data agreed with those reported by Dai where FCN-2 and CPB2 proteins were shown as biomarkers of liver fibrosis through serum proteomics analysis and quantified using ELISA in a cohort of 46 CHB subjects [20].